Table of Contents

• Trial overview
• Who was studied
• What was tested
• Study design and phase
• Outcomes measured
• What the trial means for patients

Trial overview

The main trial in the provided data is TOXSIALO-TRIAL, which studied treatment for drooling in children with cerebral palsy.^[1] It compared a scopolamine patch, which is a form of Hyoscine in this dataset, with botulinum toxin injections into the salivary glands.^[1] The study was completed and enrolled 132 participants.^[1]

Who was studied

The trial focused on children aged 4 years and older who had cerebral palsy and pathological drooling, meaning drooling that is a real medical problem rather than a small normal amount.^[1] The study description does not give more detailed participation rules, so only this target group can be confirmed from the source data.^[1]

What was tested

The trial tested a scopolamine patch against botulinum toxin injections as part of a standardized rehabilitation guidance plan.^[1] In the source data, the patch is listed as SCOPODERM TTS 1 mg/72 hours, and the injection treatment is listed as BOTOX 100 units.^[1] The goal was not simply to give treatment, but to compare which approach better reduced drooling over time.^[1]

Study design and phase

This was an interventional study, which means the researchers assigned treatments and then measured the results.^[1] It was a Phase 3 trial, a later stage of research that usually compares treatments in a larger group of patients.^[1] The study included 132 participants, which shows that it was designed to gather meaningful comparative data in a pediatric population.^[1]

Outcomes measured

The main outcome was the change in the degree and impact of drooling from the start of treatment to 15 months later.^[1] Researchers measured this using the DIS scale, which is a scoring tool for drooling severity and how much it affects daily life.^[1] This means the trial was not only asking whether drooling changed, but also whether the change mattered in everyday life for the child and family.^[1]

What the trial means for patients

For families, this trial is an example of research looking at practical ways to manage drooling in children with cerebral palsy.^[1] The study compares two active treatment approaches rather than testing Hyoscine alone against no treatment.^[1] Because the trial is completed, it adds information about how these options were studied over a long follow-up period of 15 months.^[1]